Biography
Adam Sternberg is an associate in Weil’s Tax Department and is based in New York. Adam participates in the representation of Firm clients with respect to the tax aspects of a wide range of corporate transactions.
Adam has been part of the teams advising:
- Advent International in its acquisition of a stake in Imperial Dade (a portfolio company of Bain Capital and Audax)
- American Securities in its acquisition of FullBloom Education
- Blackstone in its investment in InCloud
- Corporate Finance Group Inc. (a portfolio company of Carlyle and CVC Capital Partners) in its acquisition of PAS Financial Advisory AG
- Diversified Healthcare Trust, a real estate investment trust in a $941 million offering of zero coupon senior secured notes due 2026
- Eli Lilly & Company in its acquisition of a manufacturing facility located in Pleasant Prairie, WI
- Growthcurve Capital in its majority investment in PureFacts Financial Solutions Inc.
- Office Properties Income Trust in its $300 million 144A/Reg S offering of 9.000% senior secured notes due 2029
- Reservoir Capital Group, LLC in sale of its majority stake in ClearCaptions LLC to CC Opportunities, LLC
- TPG Growth in its acquisition of a majority stake in Morrow Sodali
Prior to joining Weil, Adam was a Tax associate at another international law firm.
Adam received his LL.M. from New York University School of Law, his J.D., cum laude, from Fordham University School of Law and his B.A. from the University of Maryland, College Park.
Awards and Recognition, Speaking Engagements
Latest Thinking
-
Updated Procedures for Section 355 Private Letter Rulings: Rev. Proc. 2024-24 and Notice 2024-38
Blog Post — Tax Blog
— By
Devon Bodoh,
Graham Magill,
Blake Bitter,
Madeline Joerg,
Grant Solomon and
Adam Sternberg
— May 13, 2024
On May 1, 2024, the Treasury Department and Internal Revenue Service (the “Treasury” and “IRS,” respectively) issued Revenue Procedure (“Rev. Proc.”) 2024-24 and Notice 2024-38 (collectively, the “Guidance”). The Rev. Proc. provides procedures for requesting private letter rulings from the IRS relating to certain matters pertaining to transactions intended to qualify under Section 355 and related provisions of the Internal Revenue Code of 1986, as amended (the “Code”).[1] Notice 2024-38 describes the views and concerns of the Treasury and IRS regarding certain matters addressed in the Rev. Proc. The Guidance modifies Rev. Proc. 2017-52 and supersedes Rev. Proc. 2018-53. ...
Firm News & Announcements
- Weil Advises GrowthCurve in its Majority Investment in Purefacts Deal Brief — August 01, 2024
- Weil Advises CFGI on Agreement to Acquire PAS Financial Advisory AG Deal Brief — May 06, 2024